Neovasc Announces $11.5 Million Registered Direct Offering Priced At-The-Market
12 juin 2020 09h00 HE
|
Neovasc, Inc.
Vancouver, BC, June 12, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE --Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ: NVCN / TSX: NVCN) announced today that it has entered into definitive...
Genius Brands International Announces $2.8 Million Registered Direct Offering
07 mai 2020 09h15 HE
|
Genius Brands International, Inc.
BEVERLY HILLS, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- Genius Brands International, Inc. (“Genius Brands” or the “Company”) (NASDAQ: GNUS) announced today that it has entered into a securities...
Akers Biosciences Announces $4.6 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
07 avr. 2020 10h53 HE
|
Akers Biosciences Inc.
Thorofare, New Jersey, April 07, 2020 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (the “Company”) (NASDAQ: AKER), a developer of rapid health information technologies, today announced that it has...
Emerald Bioscience Announces $2.0 Million Registered Direct Offering
21 nov. 2019 09h12 HE
|
Emerald Bioscience, Inc.
Long Beach, CA, Nov. 21, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Emerald Bioscience, Inc. (OTCQB: EMBI) (“Emerald”), a biopharmaceutical company focused on bioengineered cannabinoid-based...
iFresh, Inc. Announces Pricing of Approximately $2.6 Million Registered Direct Offering
19 oct. 2018 09h34 HE
|
iFresh, Inc
NEW YORK, Oct. 19, 2018 (GLOBE NEWSWIRE) -- iFresh, Inc. (“iFresh” or “the Company”) (NASDAQ:IFMK), a leading Asian American grocery supermarket chain and online grocer, announced today it has...
VBI Vaccines Announces Closing of Public Offering and Concurrent Registered Direct Offering of Common Shares
31 oct. 2017 08h30 HE
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., Oct. 31, 2017 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) (TSX:VBV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and...
VBI Vaccines Announces Proposed Concurrent Public Offering and Registered Direct Offering of Common Shares
25 oct. 2017 16h01 HE
|
VBI Vaccines, Inc.
CAMBRIDGE, Mass., Oct. 25, 2017 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq:VBIV) (TSX:VBV) (VBI), a commercial-stage biopharmaceutical company developing next-generation infectious disease and...